Founders Financial Alliance’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
1,177
+753
+178% +$129K 0.03% 402
2026
Q1
$71.7K Buy
424
+371
+700% +$63.4K 0.01% 484
2025
Q4
$9K Sell
53
-321
-86% -$52.1K ﹤0.01% 515
2025
Q3
$54K Buy
374
+321
+606% +$43.8K 0.01% 492
2025
Q2
$6.74K Sell
53
-296
-85% -$36.3K ﹤0.01% 480
2025
Q1
$44.7K Buy
349
+296
+558% +$40.1K 0.01% 450
2024
Q4
$7.04K Hold
53
﹤0.01% 503
2024
Q3
$7.75K Hold
53
﹤0.01% 506
2024
Q2
$7.3K Hold
53
﹤0.01% 491
2024
Q1
$7.3K Hold
53
﹤0.01% 495
2023
Q4
$7.23K Hold
53
﹤0.01% 448
2023
Q3
$6.5K Hold
53
﹤0.01% 434
2023
Q2
$6.75K Hold
53
﹤0.01% 460
2023
Q1
$6.86K Hold
53
﹤0.01% 414
2022
Q4
$6.97K Hold
53
﹤0.01% 432
2022
Q3
$6K Sell
53
-26
-33% -$3.23K ﹤0.01% 431
2022
Q2
$9K Buy
79
+12
+18% +$1.42K ﹤0.01% 437
2022
Q1
$9K Hold
67
﹤0.01% 397
2021
Q4
$10K Hold
67
﹤0.01% 430
2021
Q3
$11K Hold
67
0.01% 392
2021
Q2
$11K Hold
67
0.01% 414
2021
Q1
$10K Buy
+67
New +$10.6K ﹤0.01% 400

Other funds holding IBB

Founders Financial Alliance's IBB Position: Q2 2026 in Review

Founders Financial Alliance increased its iShares Biotechnology ETF (IBB) stake by 178% in Q2 2026, buying an estimated $129K and bringing the position to 1,177 shares worth $224K. The position accounts for 0.03% of the portfolio, ranked #402.

Founders Financial Alliance first reported a position in IBB in Q1 2021 and has held it in 22 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Founders Financial Alliance held 1,177 shares of iShares Biotechnology ETF worth $224K as of Q2 2026.
  • Founders Financial Alliance bought 753 iShares Biotechnology ETF shares in Q2 2026, an estimated $129K.
  • iShares Biotechnology ETF made up 0.03% of Founders Financial Alliance's portfolio in Q2 2026, its #402 holding.
  • Founders Financial Alliance first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 22 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.